表紙
市場調查報告書
商品編碼
1030002

數位治療(DTx):各產品類型(設備,軟體),各應用領域(預防應用,治療/看護相關應用),各地區的全球市場規模預測(∼2028年)

Digital Therapeutics Market Forecasts to 2028 - Global Analysis By Product Type (Device, Software), Application (Preventive Applications, Treatment/Care-related Applications) and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 150+ Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

數位治療(DTx)的市場規模,2020年為35億美金,在預測期間內預計以21.5%的年複合成長率成長,至2028年達到166億2,000萬美元。

創業投資大幅增加,預防醫療受到高度關注,可預防的慢性疾病的發生率上升等,是促進市場成長的主要原因。可是,患者資料的隱私相關疑慮,來自傳統的醫療機關的抵抗,患者對數位治療方法引進的消極性等妨礙市場成長。

本報告提供數位治療(DTx)的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,Covid-19的影響,各產品類型、應用、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 產品類型

  • 終端
  • 軟體

第6章 各銷售管道

  • 從企業到消費者(B2C)
    • 看護者
    • 患者
  • 企業間(B2B)
    • 僱用主人
    • 醫療保健提供者
    • 付款人
    • 製藥企業

第7章 各應用領域

  • 預防應用
    • 生活方式管理
    • 營養
    • 肥胖
    • 前糖尿病
  • 治療/照護相關的應用
    • 心血管疾病(CVD)
    • 中樞神經系統(CNS)障礙(心理健康障礙)
    • 慢性呼吸疾病
    • 糖尿病
    • 腸胃障礙(GID)
    • 服藥遵守
    • 肌肉骨骼系統障礙
    • 復健和患者照護
    • 戒煙
    • 物質使用和成癮的管理

第8章 各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東及非洲

第9章 主要發展

  • 契約,夥伴關係,合作,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他重要策略

第10章 企業簡介

  • 2Morrow, Inc.
  • Akili Interactive Labs, Inc
  • Canary Health, Inc.
  • Click Therapeutics, Inc
  • Happify, Inc
  • Kaia Health
  • Livongo Health, Inc
  • Mango Health, Inc.
  • Medtronic Plc
  • Noom Health, Inc.
  • Omada Health, Inc
  • Pear Therapeutics, Inc
  • Propeller Health
  • Proteus Digital Health, Inc
  • Twine Health, Inc.
  • Voluntis, Inc
  • Welldoc, Inc
目錄
Product Code: SMRC20920

According to Stratistics MRC, the Global Digital Therapeutics Market is accounted for $3.50 billion in 2020 and is expected to reach $16.62 billion by 2028 growing at a CAGR of 21.5% during the forecast period. Significant increase in venture capital investments, growing focus on preventive healthcare, rising incidence of preventable chronic diseases are the major factors propelling the market growth. However, patient data privacy concerns, resistance from traditional healthcare providers, and reluctance among patients to adopt digital therapeutics are hampering the market growth.

Digital therapeutics provides evidence-based treatment with software that replaces or complements existing treatment for a disease. It is a subdivision of digital health, and not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on the clinical outcomes of the patient. For instance, digital therapeutics does not include consumer health-oriented technologies such as pedometers and calorie counters. It is new types of healthcare products that uses digital technology to prevent, control, or treat medical conditions.

Based on product type, the software segment is estimated to have a lucrative growth due to the rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use existing software and develop new and advanced features to make them more effective and affordable. Thus, this factor is anticipated to help in increasing the digital therapeutics market size in the near future.

By geography, North America is going to have a lucrative growth during the forecast period due to the increase in geriatric population, rise in incidences of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure. Furthermore, the U.S. FDA released guidelines to expand the availability of digital health therapeutic devices for psychiatric conditions. Owing to this, the FDA intended to support individuals that were following home quarantine orders or practicing social distancing, without the need for in-clinic visits during the COVID-19 public health emergency. This would also ease burdens on healthcare facilities and reduce the risk of exposure to the virus.

Some of the key players profiled in the Digital Therapeutics Market include 2Morrow, Inc., Akili Interactive Labs, Inc, Canary Health, Inc., Click Therapeutics, Inc, Happify, Inc, Kaia Health, Livongo Health, Inc, Mango Health, Inc., Medtronic Plc, Noom Health, Inc., Omada Health, Inc, Pear Therapeutics, Inc, Propeller Health, Proteus Digital Health, Inc, Twine Health, Inc., Voluntis, Inc, and Welldoc, Inc.

Product Types Covered:

  • Device
  • Software

Sales Channels Covered:

  • Business-to-Consumer (B2C)
  • Business-to-Business (B2B)

Applications Covered:

  • Preventive Applications
  • Treatment/Care-related Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Therapeutics Market, By Product Type

  • 5.1 Introduction
  • 5.2 Device
  • 5.3 Software

6 Global Digital Therapeutics Market, By Sales Channel

  • 6.1 Introduction
  • 6.2 Business-to-Consumer (B2C)
    • 6.2.1 Caregivers
    • 6.2.2 Patients
  • 6.3 Business-to-Business (B2B)
    • 6.3.1 Employers
    • 6.3.2 Healthcare Provider
    • 6.3.3 Payers
    • 6.3.4 Pharmaceutical Companies

7 Global Digital Therapeutics Market, By Application

  • 7.1 Introduction
  • 7.2 Preventive Applications
    • 7.2.1 Lifestyle Management
    • 7.2.2 Nutrition
    • 7.2.3 Obesity
    • 7.2.4 Prediabetes
  • 7.3 Treatment/Care-related Applications
    • 7.3.1 Cardiovascular Disease (CVD)
    • 7.3.2 Central Nervous System (CNS) Disorders (Mental Health Disorder)
    • 7.3.3 Chronic Respiratory Disorders
    • 7.3.4 Diabetes
    • 7.3.5 Gastrointestinal Disorder (GID)
    • 7.3.6 Medication Adherence
    • 7.3.7 Musculoskeletal Disorders
    • 7.3.8 Rehabilitation & Patient Care
    • 7.3.9 Smoking Cessation
    • 7.3.10 Substance Use & Addiction Management

8 Global Digital Therapeutics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 2Morrow, Inc.
  • 10.2 Akili Interactive Labs, Inc
  • 10.3 Canary Health, Inc.
  • 10.4 Click Therapeutics, Inc
  • 10.5 Happify, Inc
  • 10.6 Kaia Health
  • 10.7 Livongo Health, Inc
  • 10.8 Mango Health, Inc.
  • 10.9 Medtronic Plc
  • 10.10 Noom Health, Inc.
  • 10.11 Omada Health, Inc
  • 10.12 Pear Therapeutics, Inc
  • 10.13 Propeller Health
  • 10.14 Proteus Digital Health, Inc
  • 10.15 Twine Health, Inc.
  • 10.16 Voluntis, Inc
  • 10.17 Welldoc, Inc

List of Tables

  • Table 1 Global Digital Therapeutics Market Outlook, By Region (2019-2028) ($MN)
  • Table 2 Global Digital Therapeutics Market Outlook, By Product Type (2019-2028) ($MN)
  • Table 3 Global Digital Therapeutics Market Outlook, By Device (2019-2028) ($MN)
  • Table 4 Global Digital Therapeutics Market Outlook, By Software (2019-2028) ($MN)
  • Table 5 Global Digital Therapeutics Market Outlook, By Sales Channel (2019-2028) ($MN)
  • Table 6 Global Digital Therapeutics Market Outlook, By Business-to-Consumer (B2C) (2019-2028) ($MN)
  • Table 7 Global Digital Therapeutics Market Outlook, By Caregivers (2019-2028) ($MN)
  • Table 8 Global Digital Therapeutics Market Outlook, By Patients (2019-2028) ($MN)
  • Table 9 Global Digital Therapeutics Market Outlook, By Business-to-Business (B2B) (2019-2028) ($MN)
  • Table 10 Global Digital Therapeutics Market Outlook, By Employers (2019-2028) ($MN)
  • Table 11 Global Digital Therapeutics Market Outlook, By Healthcare Provider (2019-2028) ($MN)
  • Table 12 Global Digital Therapeutics Market Outlook, By Payers (2019-2028) ($MN)
  • Table 13 Global Digital Therapeutics Market Outlook, By Pharmaceutical Companies (2019-2028) ($MN)
  • Table 14 Global Digital Therapeutics Market Outlook, By Application (2019-2028) ($MN)
  • Table 15 Global Digital Therapeutics Market Outlook, By Preventive Applications (2019-2028) ($MN)
  • Table 16 Global Digital Therapeutics Market Outlook, By Lifestyle Management (2019-2028) ($MN)
  • Table 17 Global Digital Therapeutics Market Outlook, By Nutrition (2019-2028) ($MN)
  • Table 18 Global Digital Therapeutics Market Outlook, By Obesity (2019-2028) ($MN)
  • Table 19 Global Digital Therapeutics Market Outlook, By Prediabetes (2019-2028) ($MN)
  • Table 20 Global Digital Therapeutics Market Outlook, By Treatment/Care-related Applications (2019-2028) ($MN)
  • Table 21 Global Digital Therapeutics Market Outlook, By Cardiovascular Disease (CVD) (2019-2028) ($MN)
  • Table 22 Global Digital Therapeutics Market Outlook, By Central Nervous System (CNS) Disorders (Mental Health Disorder) (2019-2028) ($MN)
  • Table 23 Global Digital Therapeutics Market Outlook, By Chronic Respiratory Disorders (2019-2028) ($MN)
  • Table 24 Global Digital Therapeutics Market Outlook, By Diabetes (2019-2028) ($MN)
  • Table 25 Global Digital Therapeutics Market Outlook, By Gastrointestinal Disorder (GID) (2019-2028) ($MN)
  • Table 26 Global Digital Therapeutics Market Outlook, By Medication Adherence (2019-2028) ($MN)
  • Table 27 Global Digital Therapeutics Market Outlook, By Musculoskeletal Disorders (2019-2028) ($MN)
  • Table 28 Global Digital Therapeutics Market Outlook, By Rehabilitation & Patient Care (2019-2028) ($MN)
  • Table 29 Global Digital Therapeutics Market Outlook, By Smoking Cessation (2019-2028) ($MN)
  • Table 30 Global Digital Therapeutics Market Outlook, By Substance Use & Addiction Management (2019-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.